Wednesday, February 22, 2012

Research and Markets: Biotech 2011-Life Sciences: Looking Back to See Ahead.

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/12212f/biotech_2011life) has announced the addition of the "Biotech 2011-Life Sciences: Looking Back to See Ahead" report to their offering.

Burrill & Company's 25th annual report on the biotech industry.

Reinventing the Industry:

Considered required reading by top executives in the life science industry, this book is an invaluable, one-stop resource to make sense of the changing landscape.

In Looking Back to See Ahead, You Will Discover:

* How pharmaceutical companies are reinventing themselves to address their pipeline problems and the competition from generics

* New strategies investors are pursuing to improve their returns

* How the convergence of wireless, mobile, and Internet technologies is making personalized medicine a reality

* The global interplay between science, business, regulatory, reimbursement, politics and policy

Comprehensive, unparalleled coverage of key trends makes Looking Back to See Ahead a critical resource for senior executives, as well as business development, sales, investment, legal, economic development, and other professionals who support the industry, to stay competitive in a fast-moving world.

Key Topics Covered:

* Introduction: Looking Back

* Chapter 2: Reinventing an Industry

* Chapter 3: Mapping the Future

* Chapter 4: Mending a Broken System

* Chapter 5: Seeking Balance

* Chapter 6: Emerging Markets Fuel Growth

* Chapter 7: Addressing Global Challenges

* Chapter 8: Shifting Risk

* Chapter 9: Playing by New Rules

* Chapter 10: Seeing Ahead

List of Charts:

* Chapter 1: LOOKING BACK

* Chapter 2: REINVENTING AN INDUSTRY

* Chapter 3: MAPPING THE FUTURE

* Chapter 4: MENDING A BROKEN SYSTEM

* Chapter 5: SEEKING BALANCE

* Chapter 6: EMERGING MARKETS FUEL GROWTH

* Chapter 7: ADDRESSING GLOBAL CHALLENGES

* Chapter 8: SHIFTING RISK

* Chapter 9: PLAYING BY NEW RULES

For more information visit http://www.researchandmarkets.com/research/12212f/biotech_2011life

No comments:

Post a Comment